Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update

Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these results with investors at the 39^th Annual J.P. Morgan Virtual Healthcare Conference. Novocure also plans to highlight key clinical and product development programs.

Fourth quarter and full year 2020 highlights include:

Three months ended December 31,

Twelve months ended December 31,

2020

2019

% Change

2020

2019

% Change

(unaudited)

(audited)

Novocure NASDAQ:NVCR NVCR Rankings #2409 Ranked by Market Cap N/A Ranked by Dividends NVCR Latest News Aug 28, 2025 Novocure Announces Upcoming Investor Events Aug 25, 2025 Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain Aug 20, 2025 Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer Jul 24, 2025 Novocure Reports Second Quarter 2025 Financial Results Jul 1, 2025 Novocure to Present Final Secondary Endpoint Data from the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) in Pancreatic Cancer at the ESMO Gastrointestinal Cancers Congress 2025 NVCR Latest SEC Filings Aug 28, 2025 [8-K] NovoCure Limited Reports Material Event Aug 13, 2025 [SCHEDULE 13G] NovoCure Limited SEC Filing Aug 5, 2025 [SCHEDULE 13G/A] NovoCure Limited SEC Filing Jul 30, 2025 [Form 4] NovoCure Limited Insider Trading Activity Jul 24, 2025 [8-K] NovoCure Limited Reports Material Event NVCR Stock Data Market Cap 1.38B Float 100.58M Insiders Ownership 9.81% Institutions Ownership 86.47% Short Percent 4.67% Industry Medical Devices Sector Surgical & Medical Instruments & Apparatus Website Link Country Switzerland City ST. HELIER Related Articles Continue reading with these related stories $TLYS Top Gainer Tilly's, Inc. Reports Fiscal 2025 Second Quarter Operating Results Sep 3, 2025 +28.08% earnings $AI Top Loser C3 AI Announces Fiscal First Quarter 2026 Financial Results Sep 3, 2025 -15.89% earnings $NVCR Same Company Novocure Announces Upcoming Investor Events Aug 28, 2025 conferences $NVCR Same Company Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain Aug 25, 2025 $NVT Related nVent Expands Data Center Solutions Manufacturing with New U.S. Production Facility Sep 3, 2025 $MYE Related Myers Industries Announces Quarterly Dividend Sep 3, 2025 dividends $RMD Related Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority Sep 3, 2025 $SRZN Related Surrozen to Present at Upcoming Healthcare Investor Conference Sep 3, 2025 conferences $NDLS Trending Noodles & Company Announces Review of Strategic Alternatives to Maximize Shareholder Value Sep 3, 2025 View All Latest News Explore About FAQ Rhea-AI Sitemap Legal Terms of Use Cookie Notice Privacy Policy Links RSS feed Discord Server Facebook Reddit © 2020-2025 StockTitan.net - Your Edge is Information | Information Only - Not Investment Advice Login Please enter your login and password Email address Password Forgot password? LOGIN Close Don't have an account? Sign Up! Forgot Password Please enter your email address Email address RECOVER Close Sign Up To create a free account, please fill out the form below. Username Email address Password I accept the user agreement Sign me up for the newsletter CREATE ACCOUNT Close Already have an account? Login